Millions Were Left With Heartburn and Acid-Reflux Pain When Ranitidine (Zantac) Was Recalled
Here are a few more recommendations on how to cope with heartburn and acid reflux in the wake of the Zantac antacid recall
Thursday, September 17, 2020 - Zantac, the world's leading heartburn and acid reflux medicine, was recalled by the FDA earlier in the year because scientist that test such drugs found elevated levels of NDMA, a known carcinogen to be present. The FDA has known for years that ranitidine and other medicines contain the carcinogen and set limits of 96 ng per tablet as allowable. Online pharmacy Valisure immediately contacted the FDA to demand a ranitidine recall when scientists found thousands of times more NDMA than thought safe. Sanofi, the maker of Zantac, immediately complied and pulled the product from store shelves. More than a month later, the FDA followed suit and added that ranitidine by any brand name recalled, and for people to throw out what stock they had already bought.
The ranitidine recall immediately caused a variety of health difficulties that heartburn patients were used to solving by taking a pill. Medical societies are recommending basic, straightforward lifestyle strategies that former Zantac users should consider when addressing their heartburn pain relief needs. According to the Gastrointestinal Society, heartburn, acid reflux are subsets of gastroesophageal reflux disease (GERD), the burning sensation in the chest caused by the acidic contents of the stomach spilling up into the esophagus. GERD is experienced by millions of people every day that overeat or eat spicey acidic foods and drinks like caffeine in coffee and alcohol. About one out of every four adults in North America has heartburn or acid reflux at one point in their lives or another. Zantac acid reflux stomach cancer attorneys offer a free consultation and no obligation to file a claim.
The stomach has a protective lining that insulates us from digestive acids but the esophagus does not. The lower esophageal sphincter valve is a one-way valve designed to open allowing food to enter the stomach, and then closing down behind the food. When the sphincter valve malfunctions, food can backflow up into the esophagus where acid can burn the acid tissue. Heartburn is an upper gastrointestinal (GI) tract burn. There are many symptoms of GERD such as chest pain, a feeling of acids backing up into the mouth, and tooth decay as stomach acids gradually erode protective tooth enamel. Other organs that can be damaged by stomach acid include the larynx, esophagus, and mouth. With ranitidine products like Zantac off of the market, heartburn sufferers are advised to keep a journal of what they eat and to avoid those foods that cause discomfort.
The leading cause of heartburn and acid reflux pain, however, is obesity. Overeating also causes heartburn pain. Those suffering from heartburn indigestion should reduce meal sizes as large meals will tend to spill up and out more frequently than small. Limiting food intake to three reasonably sized meals per day and reducing coffee and alcohol intake is a good start to losing weight and getting acid reflux under control.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.